Efficacy of Interleukin-2 in Triple Negative Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: DRUG: Human Interleukin-2 (IL-2) (Proleukin)
Sponsor: Gregory Knapp